MoneyWorks4Me

Concord Biotech informs about updates

11 Oct 2023 Evaluate
Concord Biotech has informed that it enclosed trading plan for acquiring and selling of equity shares of the Company, formulated by Ravi Kapoor, Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..